WallStreetZenWallStreetZen

NASDAQ: TELO
Telomir Pharmaceuticals Inc Stock Ownership - Who owns Telomir Pharmaceuticals?

Insider buying vs selling

Have Telomir Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Shore Trust Bay10% Owner2024-02-1349,000$7.00
$343.00kBuy
Shore Trust Bay10% Owner2024-02-1340,000$7.00
$280.00kBuy
Shore Trust Bay10% Owner2024-02-1349,000$7.00
$343.00kBuy

1 of 1

TELO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TELO insiders and whales buy or sell their stock.

TELO Shareholders

What type of owners hold Telomir Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Shore Trust Bay11.12%3,292,696$22.60MInsider
Christopher C. Chapman Jr.3.29%975,610$6.70MInsider
Craig Eagle1.65%487,805$3.35MInsider
Nathen Fuentes0.34%101,134$694.28kInsider
Hugh McColl Iii0.16%48,781$334.88kInsider
Talhia Tuck0.16%48,781$334.88kInsider
Bradley Kroenig0.16%48,781$334.88kInsider

1 of 1

TELO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TELO0.00%16.90%Net BuyingNet Buying
INMB12.71%40.66%Net BuyingNet Buying
ATNM15.63%84.37%
PSTX46.85%40.59%Net SellingNet Selling
CMPX62.59%12.24%Net BuyingNet Selling

Telomir Pharmaceuticals Stock Ownership FAQ

Who owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals (NASDAQ: TELO) is owned by 0.00% institutional shareholders, 16.90% Telomir Pharmaceuticals insiders, and 83.10% retail investors. Shore Trust Bay is the largest individual Telomir Pharmaceuticals shareholder, owning 3.29M shares representing 11.12% of the company. Shore Trust Bay's Telomir Pharmaceuticals shares are currently valued at $22.60M.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.